The DLL1 ligand was observed to be the most expressed Notch pathway component in MYCN amplified neuroblastoma cells and its downregulation, with miRNAs, induced differentiation and an arrest of cell proliferation. This evidence concerns the gene MYCN and neuroblastoma.